Wang Xia, Yu Weihua, Fu Xue, Ke Meiling, Xiao Qian, Lü Yang
Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Institutes of Neuroscience, Chongqing Medical University, Chongqing 400016, China.
Neurosci Lett. 2018 Nov 20;687:99-103. doi: 10.1016/j.neulet.2018.09.037. Epub 2018 Sep 21.
TGFβ-Smad signaling is involved in the modulation of β-amyloid (Aβ) clearance in microglia. This signaling is impaired in the brain of Alzheimer's disease (AD). Chitotriosidase (CHIT1) is elevated in the cerebrospinal fluid and peripheral blood of AD patients, and has been reported to augment TGFβ signaling in fibroblast and T cells. In this study, we investigated the role of CHIT1 in TGFβ-Smad signaling and Aβ phagocytosis in N9 microglia. We found that CHIT1 significantly enhanced TGFβ1-induced expression of TβRI (TGFβ receptor I) and activation of Smad signaling. CHIT1 did not affect Aβ uptake in microglia by itself, but did enhance TGFβ1-induced phagocytosis of Aβ, which was blocked by pretreatment with SB431542 (TβRI inhibitor). These results indicate that CHIT1 may play a protective role in Aβ clearance by enhancing TGFβ signaling in microglia.
转化生长因子β(TGFβ)-Smad信号通路参与小胶质细胞中β-淀粉样蛋白(Aβ)清除的调节。该信号通路在阿尔茨海默病(AD)患者大脑中受损。几丁质酶(CHIT1)在AD患者的脑脊液和外周血中升高,并且据报道可增强成纤维细胞和T细胞中的TGFβ信号通路。在本研究中,我们研究了CHIT1在N9小胶质细胞中TGFβ-Smad信号通路和Aβ吞噬作用中的作用。我们发现CHIT1显著增强TGFβ1诱导的TβRI(TGFβ受体I)表达和Smad信号通路的激活。CHIT1本身不影响小胶质细胞对Aβ的摄取,但确实增强了TGFβ1诱导的Aβ吞噬作用,而SB431542(TβRI抑制剂)预处理可阻断这种作用。这些结果表明,CHIT1可能通过增强小胶质细胞中的TGFβ信号通路在Aβ清除中发挥保护作用。